# Executive Summary: Agent Schools Framework for Epitope Mapping  
## Computational Strategy for Glycoconjugate Vaccine Research

---

## 1. Problem and Motivation

Epitope mapping for glycoconjugate vaccines is a **multidisciplinary** problem that spans:

- Immunology (B‑cell epitope recognition, immune dominance, tolerance)
- Glycobiology (glycan structure, linkages, conformations)
- Computational chemistry (3D structure prediction, docking, scoring)
- Machine learning (deep models on sequences and structures)
- Bioinformatics (database mining, conservation, serotype diversity)

Most labs cannot field deep expertise in all of these domains simultaneously, and **general-purpose LLMs** typically lack the depth, reliability, and tool-awareness required for rigorous, niche scientific work.[web:19][web:22]

The goal is to build a **computational strategy** for:
> “Computational Strategy for Epitope Mapping of Glycoconjugate Vaccines using Deep Learning”

using a **multi-agent AI system** where each agent is trained and validated as a domain specialist, then deployed into a Virtual Lab–style research environment inspired by Swanson et al. (“The Virtual Lab”).[web:19][web:22][web:25]

---

## 2. High-Level Solution

### 2.1 Core Idea

Combine two layers:

1. **Agent Schools**  
   A training framework where each LLM-based agent is:
   - Assigned a **specific scientific role** (e.g., Glyco‑Immunologist, Computational Chemist)
   - Given a **curriculum** (papers, tools, databases)
   - Put through **autonomous study + RAG fine-tuning**
   - **Tested** by “Teacher/Scientific Critic” agents via quizzes and scenario problems
   - Only **certified** after meeting performance thresholds

2. **Virtual Lab** (adapted from Swanson et al.)  
   A research orchestration layer where:
   - A **PI agent** leads a team of certified specialist agents
   - Work proceeds via **team meetings** (high-level reasoning) and **individual meetings** (concrete tasks, code, analyses)
   - A **Scientific Critic** agent continuously evaluates reasoning, catches errors, and pushes for rigor[web:19][web:22][web:25]

This system is designed so that a **team of diverse specialists** outperforms a single “super-intelligent” generalist LLM on complex, interdisciplinary research tasks.[web:19][web:22]

---

## 3. Research Objective (Epitope Mapping)

### 3.1 Scientific Goal

Design an AI-driven workflow to:

- Predict **B-cell epitopes** on glycoconjugate vaccine constructs (glycan + carrier protein)
- Model **glycan–protein structure** and epitope accessibility
- Use **deep learning** to rank and interpret predicted epitopes
- Propose **rational design changes** to improve immunogenicity and coverage
- Output **experiment-ready hypotheses** (epitope lists, constructs, and validation plans)

### 3.2 Scope

- Focus primarily on **B-cell epitopes** (conformational and glycan-associated)
- Target one or more **bacterial glycoconjugate vaccines** (e.g., pneumococcal, meningococcal) as running examples
- Provide a framework that can be **generalized** to other glycoconjugate or protein vaccines

---

## 4. Agent Schools Framework

### 4.1 Specialized Agent Roles

The system trains six main agent types:

| Agent | Expertise Focus | Core Responsibilities |
|-------|-----------------|-----------------------|
| **Glyco‑Immunologist** | Humoral immunity, glycobiology, vaccine immunology | Epitope immunogenicity, immune dominance, carrier protein effects |
| **Computational Chemist** | Structure prediction, docking, MD, scoring | AlphaFold‑style structure modeling, glycan conformations, Rosetta/scoring workflows |
| **Machine Learning Specialist** | Deep learning, representation learning | Model architecture, training, evaluation, interpretability for epitope prediction |
| **Bioinformatician** | Sequences, databases, comparative genomics | IEDB/PDB querying, sequence conservation, serotype coverage analysis |
| **PI Agent** | Strategy, integration, project management | Set research direction, integrate agent outputs, define workflows and priorities |
| **Scientific Critic / Teacher** | Critical evaluation, testing | Generate exams, critique reasoning, identify errors, ensure rigor |

Each agent is defined in Virtual Lab style with **title, expertise, goal, and role**, and is powered by a strong LLM plus domain tools.[web:22][web:25]

### 4.2 Agent School Phases

1. **Curriculum Design (Weeks 1–3)**  
   - PI + Human define:
     - Knowledge gaps for each agent
     - Reading lists (reviews + key primary papers)
     - Tool/documentation sets (AlphaFold, GLYCAM, Rosetta, ESM, IEDB, etc.)
   - Outputs:
     - Per-agent **curriculum** (syllabus, objectives, required tools)
     - **Assessment rubrics** and target competencies

2. **Autonomous Study (Weeks 4–9)**  
   - Each student agent:
     - Searches PubMed and other databases
     - Downloads and “reads” PDFs
     - Builds internal summaries and concept maps via RAG
   - Structured around:
     - Foundation → Intermediate → Advanced topics per agent

3. **Training & Knowledge Integration (Weeks 10–15)**  
   - Implement **RAG** per agent (vector DB + retrieval for that domain)
   - Optionally **fine-tune** or instruction-tune on curated domain examples
   - Agents practice:
     - Writing mini-reviews and SOPs
     - Explaining methods (e.g., AlphaFold for glycoproteins, ESM embeddings)
     - Designing small test workflows

4. **Testing & Certification (Weeks 16–18)**  
   - Scientific Critic acts as a “Teacher Agent”:
     - Generates quizzes and scenario questions from reading corpora
     - Evaluates conceptual depth, tool literacy, and problem-solving ability
   - Each agent must exceed a **threshold score** (e.g., ≥80%) to be “graduated”
   - Certified agents are eligible to join the Virtual Lab research team

---

## 5. Virtual Lab Research Workflow

The certified agents are then plugged into a Virtual Lab architecture similar to Swanson et al., using **team** and **individual** meetings over multiple “rounds.”[web:19][web:22][web:25]

### 5.1 Phases

**Phase 1 – Research Planning & Specification**  
- Team meeting (PI + all specialists + Critic) to:
  - Choose target pathogens and vaccine constructs
  - Decide scope (B-cell only vs. combined epitope mapping)
  - Define **success metrics** (e.g., sensitivity vs. IEDB epitopes)
- Individual meeting (Bioinformatician):
  - Audit data availability (PDB structures, glycan info, IEDB records)

**Phase 2 – Tool & Pipeline Design**  
- Team meeting to select computational components, e.g.:
  - Structure: AlphaFold‑like models for glycoproteins, possibly with glycan-aware workflows and GLYCAM-based MD for refinement
  - Feature extraction: ESM/other protein LMs, structural GNNs
  - Epitope labels: IEDB/other immune epitope databases[web:19][web:22]
  - Scoring: Rosetta or other energy/scoring tools for structural plausibility
- Output: **End-to-end pipeline design** for epitope prediction

**Phase 3 – Component Implementation**  
- Multiple **individual meetings**, one per module:
  - Computational Chemist: structure prediction + glycan ensemble tools
  - ML Specialist: feature engineering and deep learning models
  - Bioinformatician: data ingestion, labeling, and alignment tools
- Each task iterates with Critic feedback until code/specs are solid

**Phase 4 – Workflow Integration**  
- Individual meeting with PI agent:
  - Wires up modules into an orchestrated workflow:
    - Input: sequences + glycan info → structures
    - Features → ML model → epitope scores
    - Comparison against known epitopes
  - Defines:
    - Batch sizes, resource budgets
    - Iterative refinement loops (retraining, re-scoring)
    - Logging, provenance, reproducibility requirements

**Phase 5 – Validation & Interpretation**  
- Team meeting:
  - Analyze predicted epitope sets
  - Evaluate against known epitopes (IEDB) where available
  - Inspect structural models for accessibility, glycan occlusion
  - Prioritize epitopes for experimental validation
- Outputs:
  - Ranked epitope list
  - Proposed **constructs** or mutations
  - Experimental validation plan

---

## 6. Outputs and Deliverables

### 6.1 Computational Deliverables

1. **Epitope Map for Glycoconjugate Vaccine Construct**
   - List of predicted B‑cell epitopes (sequence + structural location)
   - Confidence scores, uncertainty estimates
   - Structural models illustrating epitope accessibility

2. **Trained Deep Learning Model(s)**
   - Architecture and weights
   - Training scripts and configs
   - Evaluation metrics (ROC, PR, calibration, etc.)

3. **Reproducible Pipeline**
   - From raw sequences/glycan data to ranked epitopes
   - Containerized environment (e.g., Docker)
   - Documentation (README, methods, parameters)

4. **Knowledge Assets**
   - Agent curricula and reading lists
   - SOPs and mini-reviews written by agents
   - Meeting transcripts and decision logs (optionally summarized)

### 6.2 Experimental / Wet-Lab Recommendations

- Specific epitopes and construct designs to synthesize
- ELISA / binding assay plans
- Suggested animal model experiments
- Prioritized hypotheses (highest expected chance of validation)

---

## 7. Success Metrics

### 7.1 Agent School Phase

- **Certification rate**: ≥85% of agents passing competency thresholds
- **Knowledge retention**: ≥80% on delayed re-assessments
- **Tool proficiency**: ≥90% of tools exercised correctly in practice tasks
- **Interdisciplinary understanding**: Qualitative scoring in team meetings

### 7.2 Virtual Lab Phase

- **Predictive performance**:
  - Sensitivity and specificity against known epitopes (IEDB)
  - Generalization to held-out serotypes/pathogens
- **Research efficiency**:
  - Time from initial definition to first epitope map: ≤2 weeks per run
- **Validation success**:
  - Fraction of predicted epitopes that validate experimentally (target ≥60%)
- **Robustness**:
  - Scientific Critic detection of major flaws before execution
  - Number of cycles needed to reach stable design

---

## 8. Timeline (Approximate)

- **Weeks 1–3**: Curriculum design and resource curation  
- **Weeks 4–9**: Autonomous literature study and tool familiarization  
- **Weeks 10–15**: RAG + integration + practice tasks  
- **Weeks 16–18**: Formal assessment and certification  
- **Week 19**: Virtual Lab team formation  
- **Weeks 20–27**: Module implementation (in parallel)  
- **Week 28**: Workflow integration and orchestration  
- **Weeks 29–31**: Full run(s) of the epitope mapping pipeline  
- **Weeks 32–36**: Validation planning, reporting, and dissemination  

Total: **~8–9 months** from Agent School start to fully validated computational results.

---

## 9. Comparative Advantages

| Approach | Depth | Interdisciplinarity | Reproducibility | Cost | Speed |
|----------|-------|---------------------|-----------------|------|-------|
| Single generalist LLM | Low–Medium | Low–Medium | Low | Low | High (but shallow) |
| Single-domain ML tool | High (narrow) | Low | Medium–High | Low–Medium | Medium |
| Human interdisciplinary team | Very High | Very High | High | Very High | Medium |
| **Agent Schools + Virtual Lab** | High–Very High | High | High | Medium | Medium–High |

**Key advantages of Agent Schools + Virtual Lab:**

- Builds **real, testable expertise** in each domain, beyond generic LLM knowledge[web:19][web:22]
- Uses **structured collaboration** to integrate perspectives (via team meetings and critic feedback)
- Provides a **transparent, reproducible** decision trail
- Reusable across multiple related projects once agents are trained

---

## 10. Recommended Use

- Use this framework as a **blueprint** for:
  - Internal AI‑augmented vaccine design programs
  - Grant proposals describing an AI‑driven pipeline
  - Building reusable **scientific AI agents** in your lab

- The same pattern can be adapted to:
  - Other antigen design problems (proteins, peptides)
  - ADC linker/payload design
  - Multi-target immunogen design

---

*End of `executive_summary.md`*
